Search results
Stock market today: World shares are mostly higher after rebound on Wall St
ClickOnDetroit· 5 days agoEuropean shares saw modest gains after the opening while Asian benchmarks gained upward momentum as...
Aristocrats in Disguise: 3 Blue-Chip Stocks With Stealth Growth Potential Aristocrats in Disguise: 3...
InvestorPlace· 16 hours agoThe T. Rowe Price Blue Chip Growth ETF (NYSEARCA:TCHP), for example, includes Microsoft...
How California And The Eu Work Together To Regulate Artificial Intelligence
San Francisco Chronicle· 5 days agoWhile the federal government appears content to sit back and wait, more than 40 U.S. states are considering hundreds of AI regulation bills. California, with its status as a tech-forward state ...
Stock market today: Asian shares mostly higher after rebound on Wall St
KEYT 3 Santa Barbara· 5 days agoMediaTek, a semiconductor company that provides chips for wireless communications, high-definition...
Stock market today: World shares are mostly higher after rebound on Wall St
FOX West Texas· 5 days agoEuropean shares saw modest gains after the opening while Asian benchmarks gained upward momentum as...
Artificially Intelligent
GoldSeek.com· 3 days agoThe smiling-face AI keeps us happy with the output the ugly creature produces out of our view. Whether the output is correct is a different matter.
Trade With China Is Getting Harder. New Rules Could Hit Tech, Pharma, and Finance.
Barrons.com· 2 days agoGlobal companies, however, could be caught in the middle. Most analysts expect another batch of...
How artificial intelligence is helping to identify global inequalities
Nature· 5 days agoHello, this is How to Save Humanity in 17 Goals, a podcast brought to you by Nature Careers in...
Senate Democrat pushes for expansion to copyright act to include generative AI research
FedScoop· 3 days agoAn exemption under the Digital Millennium Copyright Act should be expanded to include generative ...
JD Supra: FDA Makes Good on Its Promise to Regulate Laboratory-Developed Tests
JD Supra· 6 hours agoYesterday, the Food & Drug Administration (“FDA” or “the Agency”) issued a highly anticipated – and highly controversial – final rule, which rolls out a four-year, five-stage plan that will ...